U.S. FDA favors GSK unit’s medication to treat newborn children and kids with HIV

Overview

• Post By : Kumar Jeetendra


• Source: Reuters


• Date: 13 Jun,2020

The U.S. Food and Drug Administration has endorsed a medication to treat newborn children and kids with HIV, with the medication having been created by drugmaker GlaxoSmithKline’s HIV drugs division ViiV Healthcare, the FDA and the GSK unit said.

The FDA said on Friday it was conceding Viiv the endorsement of Tivicay and Tivicay PD tablets “for suspension to treat HIV-1 disease in pediatric patients at any rate a month old and weighing in any event 3 kgs in blend with other antiretroviral medicines”.

The medication is at present under audit by the European Medicines Agency, ViiV, in which Pfizer and Shionogi have little stakes, said in a different articulation.